crypto vs bank, Featured snippets

Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.Governor of Belgorod, Russia: Ukrainian troops fired more than 30 shells in Belgorod within 24 hours, causing no casualties or property losses.Nearly 20,000 people were evacuated due to the spread of mountain fires in southern California. A mountain fire broke out in Malibu, Los Angeles County, southern California on the evening of the 9th, and the fire spread rapidly. As of the evening of the 10th, the fire area has exceeded 1,100 hectares, nearly 20,000 people have been evacuated, and some buildings have been damaged by the fire. At present, no casualties have been reported.

European bond market: The market remained stable before the US inflation data was released, waiting for the ECB meeting on Thursday. On Wednesday, the European bond market remained stable, waiting for the US consumer price index (CPI) data later that day and the ECB meeting on Thursday. The yield of German 10-year government bonds did not change much, at 2.12%. Traders are waiting for the US CPI inflation data released at 21: 30 Beijing time on Wednesday, which may affect the market expectation that the Fed will cut interest rates next week. The yield of Italian 10-year government bonds also remained basically unchanged at 3.20%, and the spread between Italian government bonds and German government bonds remained at 108 basis points. The market expects the European Central Bank to cut interest rates by 25 basis points on Thursday. The yield of German two-year government bonds is sensitive to the interest rate expectations of the European Central Bank, falling by 1 basis point to 1.96%.Wuzhou Spring Festival rose by 6.55% today. Guotai Junan bought 188 million yuan in Shanghai Haiyang West Road, and Wuzhou Spring Festival rose by 6.55% today, with a turnover of 3.902 billion yuan and a turnover rate of 37.90%. After-hours data show that Guotai Junan bought 188 million yuan in Shanghai Haiyang West Road, and the special seat of Shanghai Stock Connect bought 88.9787 million yuan and sold 58.7513 million yuan.The Taiwan Affairs Office of the State Council introduced the situation of the 2024 Shanghai-Taipei Twin Cities Forum. The Taiwan Affairs Office held a regular press conference. Spokesperson Zhu Fenglian said that it is understood that the 2024 Shanghai-Taipei Urban Forum will be held in Taipei on December 17, and Shanghai will send a delegation to Taiwan to attend the forum. With the theme of "Smart Governance for a Sustainable Future", the forum will promote the interactive exchanges between the two cities in terms of friendly transportation, river governance and humanistic cities. During the forum, the two cities will also sign a memorandum on exchanges and cooperation. We hope the forum will be successful.

Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee. According to the news of Changzhi News VideoNo. on December 11th, Changzhi held a meeting of leading cadres in the whole city. The meeting announced the decision of the provincial party committee, and Comrade Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.